• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Sulfamethoxazole and Trimethoprim (Bactrim) Oral Suspension

 Status: Currently in Shortage

 » Date first posted: 08/05/2014
 » Therapeutic Categories: Anti-Infective; Pediatric

Aurobindo Pharma (New 08/05/2014)

Company Contact Information:
888-238-7880, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sulfamethoxazole & Trimethoprim Oral Suspension, USP 200-40 mg / 5 mL (NDC 65862-0496-47) Currently backordered. Additional supply expected in by 1st week in August 2014. Demand increase for the drug.

Hi-Tech (Reverified 10/24/2014)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sulfamethoxazole & Trimethoprim Oral Suspension, USP (Cherry Flavor) 200-40 mg/5 mL (NDC 50383-0823-16) Currently backordered. Product to be available by end of November. Discontinuation of the manufacture of the drug.
Sulfamethoxazole & Trimethoprim Oral Suspension (Grape Flavor) 200-40 mg/5 mL (NDC 50383-0824-16) Currently backordered. Product to be available by end of November. Discontinuation of the manufacture of the drug.

STI Pharma LLC (New 11/06/2014)

Company Contact Information:
855-279-0622

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
SulfatrimTM (Sulfamethoxazole & Trimethoprim Oral Suspension, USP 200-40 mg / 5 mL) (NDC 58479-007-16) Product is currently available, but supply limited. Please contact STI Pharma Sales and Marketing for further information. Demand increase for the drug.
-
-